The most effective vaccines against covid-19 will arrive in the country in the first quarter of 2023

The Ministry of Health They would be advanced actions for this type of vaccine, known as bivalent, to arrive in Colombia during the first three months of next year. With this, they could become the fifth booster dose against COVID-19.

According to the studies carried out, bivalent vaccines can halve the risk of contracting the virus, because they protect not only from the initial variant but also from those that already exist today.

According to the studies carried out by Centers for Disease Control and Preventionthese types of upgraded vaccines can cut the risk of contracting covid in half by fighting the initial variant known in Wuhan, China and other currently existing Omicron variants.

In this investigation, reinforcing these bivalent doses was shown to provide additional protection against urgent care encounters and case hospitalizations associated with covid-19 in people who had previously received 2,3, or 4 monovalent doses.

According to what was revealed to Radio Caracol, Diego Rodríguez, medical director of the Vaccines Unit of Tecnofarma, trader of the vaccine Modern In Colombia, the Ministry of Health is reportedly carrying out actions for this type of vaccine to reach the country in the first quarter of 2023.

“The indication for the use of this vaccine, in the case of Pfizershould be used as a booster in people over 12 years of age, between 3 and 6 months after receiving the last dose. Currently in Chile and Brazil this vaccine is already in use,” Abalos said.

So far, the Ministry of Health and Social Protection has not commented on the arrival of these vaccines, but it is expected that in the coming days we will know what the procedure for acquiring this type of vaccine will be like.

Read more:  How you can lose weight after 50 years

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recent News

Editor's Pick